Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?

doi:10.4254/wjh.v16.i5.684

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (943)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

617

Figures (1-1)

Sum=696

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=126

Publishing Process of This Article

Item

Count

Browse

Download

Sum=101

May 27, 2024 (publication date) through Jun 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hepatol. May 27, 2024; 16(5): 684-687
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.684

Open in New Tab Full Size Figure Download Figure

Figure 1 Application of nanomedicine in hepatocellular carcinoma. The tumor microenvironment in hepatocellular carcinoma and over-expressed receptors on tumor cells including anti-glypican-3, asialoglycoprotein, transferrin receptor, folic acid receptor, Axl and integrins. These receptors on tumor cells are prime targets of nanontherapy, such as sorafenib loaded polymer-based nanoparticles[8-13,16]. GPC3: Anti-glypican-3; FAR: Folic acid receptor; TfR: Transferrin receptor; ASGPR: Asialoglycoprotein.

Citation: Lee HD, Yuan LY. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet? World J Hepatol 2024; 16(5): 684-687
URL: https://www.wjgnet.com/1948-5182/full/v16/i5/684.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i5.684